top of page

HER2 ICD vaccine trial findings featured on KIRO7 news

  • Writer: Kiran Dhillon
    Kiran Dhillon
  • Nov 21, 2022
  • 1 min read


CVI's Executive Director Dr. Kiran Dhillon spoke with KIRO7 news anchors Monique Ming Laven and Gary Horcher about our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD DNA vaccine. It was a great opportunity for us to share about cancer vaccine research happening at UW Medicine Cancer Vaccine Institute.


Post: Blog2_Post
bottom of page